New inhaled painkiller could offer faster relief for cancer patients

NCT ID NCT06953453

Recruiting now Symptom relief Sponsor: Lee's Pharmaceutical Limited Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times

Summary

This early-stage study tests an inhaled form of fentanyl, a strong painkiller, for cancer patients. About 100 adults with malignant tumors will receive the inhaled spray and an IV injection at different times to compare how the drug moves through the body and its safety. The goal is to see if the inhaled version can provide quick and effective pain relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Henan Tumor Hospital
RECRUITING

Zhengzhou, Henan, 450008, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Shanghai Sixth People's Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, 200233, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CANCER